By Tony Fong

NEW YORK (GenomeWeb News) – With little fanfare, Johnson & Johnson is building out its capabilities in the molecular diagnostics space with a focus on circulating tumor cells and companion diagnostics development.

In recent interviews with GenomeWeb Daily News, officials from several J&J businesses outlined a strategy focused on continuing to build out the firm's CellSearch technology as well as the development of a next-generation CTC technology in collaboration with Massachusetts General Hospital.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.